A phase IV, randomized, open-label, active controlled study to compare the effects of Tarka and Lotrel on albuminuria in hypertensive, type 2 diabetic subjects with diabetic nephropathy

Trial Profile

A phase IV, randomized, open-label, active controlled study to compare the effects of Tarka and Lotrel on albuminuria in hypertensive, type 2 diabetic subjects with diabetic nephropathy

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Amlodipine/benazepril; Verapamil/trandolapril
  • Indications Diabetic nephropathies; Hypertension; Proteinuria
  • Focus Therapeutic Use
  • Acronyms TANDEM
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 24 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top